Natural Way Laboratories S.r.l. specializes in the development, manufacture and sale of private-label food supplements in solid and liquid forms. The company operates two specialised production facilities (for solid and liquid supplements) with a product portfolio covering 15 therapeutic areas. Revenue is generated primarily in Italy, providing a comprehensive service ranging from formulation consultancy to the production of the finished product for various target markets.

Ibla Capital is an independent investment firm specialising in corporate turnarounds. It invests in small and medium-sized enterprises requiring operational and/or financial restructuring and is directly involved in the relaunch and management of its portfolio companies, guiding them towards the full realization of their potential.

Naturalia Tantum, a natural hub focused on organic ingredients backed by Assietta Private Equity, has completed its sixth acquisition. Thanks to this latest acquisition, Naturalia Tantum aims to close that year with a turnover of €45 million and to expand progressively into foreign markets.

Cross Border, thanks to its team with specific expertise in the field of CDMOs, has acted as exclusive financial advisor to the seller, managing the entire sales process and contacting over 50 national and international counterparties.
After an initial screening phase, Cross Border selected a shortlist of possible investors, prepared the documentation and assisted its client in structuring the transaction, due diligence and negotiation.
This transaction form part of an outgoing market consolidation process that involves numerous industrial and financial players, carefully selected on the basis of economic capacity and attention to the continuity of the target’s business.